血管舒张与神经保护：蛛网膜下腔出血中的镁元素传奇 - Suppr

Suppr

超能文献

Vasodilation and neuroprotection: the magnesium saga in subarachnoid hemorrhage.

作者信息

Taccone Fabio Silvio

出版信息

Crit Care Med. 2010 May;38(5):1382-4. doi: 10.1097/CCM.0b013e3181da4672.

DOI:10.1097/CCM.0b013e3181da4672

PMID:20404634

Abstract

摘要

相似文献

Vasodilation and neuroprotection: the magnesium saga in subarachnoid hemorrhage.

Crit Care Med. 2010 May;38(5):1382-4. doi: 10.1097/CCM.0b013e3181da4672.

Magnesium activation of the calcium-sensing receptor, a mechanism to reduce infarction and vasospasm in subarachnoid hemorrhage.

Crit Care Med. 2010 Oct;38(10):2083; author reply 2084-5. doi: 10.1097/CCM.0b013e3181e8ac36.

Prophylactic intravenous magnesium sulfate for treatment of aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, clinical study.

Crit Care Med. 2010 May;38(5):1284-90. doi: 10.1097/CCM.0b013e3181d9da1e.

Towards evidence-based emergency medicine: best BETs from the Manchester Royal Infirmary. BET 3. Elevation of serum magnesium may improve clinical outcome after aneursymal subarachnoid haemorrhage.

Emerg Med J. 2011 Feb;28(2):166-8. doi: 10.1136/emj.2010.108324.

Using nimodipine for patients with aneurysmal subarachnoid hemorrhage.

Nursing. 2014 Jan;44(1):67. doi: 10.1097/01.NURSE.0000438705.89850.21.

Magnesium for delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage: time for a paradigm shift?

Stroke. 2005 Dec;36(12):2530.

Temporal profile of the effects of intracisternal injection of magnesium sulfate solution on vasodilation of spastic cerebral arteries in the canine SAH model.

Acta Neurochir Suppl. 2011;110(Pt 2):39-42. doi: 10.1007/978-3-7091-0356-2_8.

Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.

Neurosurgery. 2006 Jun;58(6):1054-65; discussion 1054-65. doi: 10.1227/01.NEU.0000215868.40441.D9.

Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.

Neurosurgery. 2006 Nov;59(5):E1152; author reply E1152. doi: 10.1227/01.NEU.0000249031.26372.13.

[Prevention of vasospasm secondary to subarachnoid hemorrhage caused by ruptured aneurysm: management].

Rev Med Suisse Romande. 2000 Apr;120(4):343-9.

引用本文的文献

Pharmacologic Options for Prevention and Management of Cerebral Vasospasm in Aneurysmal Subarachnoid Hemorrhage.

Hosp Pharm. 2013 Sep;48(5 Suppl):S2-S9. doi: 10.1310/hpj48S5-S2. Epub 2013 Sep 1.

Management of aneurysmal subarachnoid hemorrhage: State of the art and future perspectives.

Surg Neurol Int. 2017 Jan 19;8:11. doi: 10.4103/2152-7806.198738. eCollection 2017.

Cerebral Vasospasm in Critically III Patients with Aneurysmal Subarachnoid Hemorrhage: Does the Evidence Support the Ever-Growing List of Potential Pharmacotherapy Interventions?

Hosp Pharm. 2014 Nov;49(10):923-41. doi: 10.1310/hpj4910-923.

Off-label use of drugs and devices in the neuroendovascular suite.

AJNR Am J Neuroradiol. 2013 Nov-Dec;34(11):2054-63. doi: 10.3174/ajnr.A3447. Epub 2013 Mar 21.

Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference.

Neurocrit Care. 2011 Sep;15(2):211-40. doi: 10.1007/s12028-011-9605-9.

Magnesium sulfate administration in subarachnoid hemorrhage.

Neurocrit Care. 2011 Sep;15(2):302-7. doi: 10.1007/s12028-011-9603-y.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验